[lcus_masonry_article]<\/p>\n
When you release research that touches on human health, you have an obligation to be clear about what it is and what it isn’t. Every one of our four research packages includes three critical documents: SAFETY_DISCLAIMER.md, METHODOLOGY.md, and honest evidence assessments.<\/p>\n
The compounds discussed in this research are not harmless supplements. Zinc above 40mg\/day can cause copper deficiency. Iron supplementation in Parkinson’s patients could accelerate neurodegeneration. Manganese is neurotoxic. Copper dysregulation is implicated in Alzheimer’s pathology. Many compounds interact with prescription medications like metformin, cholinesterase inhibitors, and L-DOPA.<\/p>\n
Someone reading about a zinc-amino acid complex for diabetes might be tempted to buy zinc supplements and self-treat. That would be a mistake. The research identifies elemental patterns \u2014 it does not validate treatments.<\/p>\n
Our V3 Known Properties Reports for Alzheimer’s and Parkinson’s include evidence grading that distinguishes between pathological relevance (whether an element is involved in the disease) and therapeutic relevance (whether targeting that element helps patients). In most cases, the pathological relevance is high but the therapeutic relevance is low or unproven.<\/p>\n
We’d rather lose credibility by being too cautious than gain attention by being too optimistic.<\/p>\n
Download the research. Read it. Think about it. Share it with your doctor if something interests you. But do not self-treat. That’s the deal.<\/p>\n
Download the research (free).<\/a><\/p>\n [\/lcus_masonry_article]<\/p>\n <\/p>\n